MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/oarrr.s206931

Медицинская библиотека · Open access rheumatology : research and reviews · 2019

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.

Peluso Rosario, Caso Francesco, Tasso Marco, Sabbatino Vincenzo, Lupoli Roberta, Dario Di Minno Matteo Nicola, Ursini Francesco, Costa Luisa, Scarpa Raffaele

СтатьяОбзорПеревод в очереди

Аннотация

Background

Psoriatic arthritis (PsA) is a chronic immune-mediated disease. It is associated with an increase in cardiovascular risk factors (obesity, hypertension, diabetes, and dyslipidemia), giving a higher risk of major adverse cardiovascular events. Patients with PsA have an increased incidence of subclinical atherosclerosis and endothelial dysfunction. The aim of this study is to perform a review of the biomarkers of subclinical atherosclerosis in patients with PsA.

Methods

A search was performed in the electronic databases (PubMed, Web of Science, Scopus, and Embase) up until July 2017. Studies were considered if they included data on biomarkers of subclinical atherosclerosis in PsA, and each article was then reviewed for quality and clinical relevance. After completing the literature search, all screened literature was summarized and discussed in our study group (CaRRDs study group).

Results

The initial search produced 532 abstracts, which were limited to 258 potentially relevant articles by preliminary review of the titles and by excluding review articles and case reports (n=274). A further 102 articles were deemed ineligible after examining the abstracts. Full texts of the remaining 156 articles were retrieved. Most articles were excluded because they were not relevant to the biomarkers of subclinical atherosclerosis in psoriasis and/or PsA. In the end, 54 articles were deemed eligible for this review.

Conclusion

Patients with PsA showed more severe atherosclerotic disease compared with patients with only psoriasis. This may have been due to the higher systemic inflammatory burden from the combination of both diseases. In patients with PsA some molecules may be considered as markers of atherosclerotic disease, and their detection may be a prognostic marker, in addition to imaging procedures, for the development of atherosclerotic disease, and could be suitable for the management of patients with PsA.

Для цитирования: Peluso Rosario, Caso Francesco, Tasso Marco, Sabbatino Vincenzo, Lupoli Roberta, Dario Di Minno Matteo Nicola, Ursini Francesco, Costa Luisa, Scarpa Raffaele. Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis.. Open access rheumatology : research and reviews. 2019. DOI: 10.2147/oarrr.s206931.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.